Form 8-K - Current report:
SEC Accession No. 0001493152-24-033501
Filing Date
2024-08-22
Accepted
2024-08-22 08:00:16
Documents
29
Period of Report
2024-08-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38552
2 ex99-1.htm EX-99.1 13254
3 ex99-1_001.jpg GRAPHIC 792336
4 ex99-1_002.jpg GRAPHIC 650969
5 ex99-1_003.jpg GRAPHIC 863094
6 ex99-1_004.jpg GRAPHIC 534949
7 ex99-1_005.jpg GRAPHIC 560500
8 ex99-1_006.jpg GRAPHIC 589940
9 ex99-1_007.jpg GRAPHIC 394268
10 ex99-1_008.jpg GRAPHIC 266774
11 ex99-1_009.jpg GRAPHIC 415279
12 ex99-1_010.jpg GRAPHIC 579768
13 ex99-1_011.jpg GRAPHIC 692319
14 ex99-1_012.jpg GRAPHIC 504528
15 ex99-1_013.jpg GRAPHIC 438232
16 ex99-1_014.jpg GRAPHIC 619741
17 ex99-1_015.jpg GRAPHIC 484327
  Complete submission text file 0001493152-24-033501.txt   11780681

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE envb-20240822.xsd EX-101.SCH 3012
19 XBRL LABEL FILE envb-20240822_lab.xml EX-101.LAB 34240
20 XBRL PRESENTATION FILE envb-20240822_pre.xml EX-101.PRE 22357
31 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3827
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 241230158
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)